Henrik Lindberg

Lund University, AstraZeneca (Sweden)

Papers

2

Total Citations

23

H-Index

2

About

Henrik Lindberg is a researcher at the forefront of biobanking and analytical biochemistry, with key contributions to large-scale sample processing and precision protein quantification. His most cited work, "Semi‐automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies" (2015, 16 citations), addresses a critical bottleneck in postgenomic medicine: the need for efficient, high-throughput handling of biological specimens. By developing a robotic system for 384-tube format processing, Lindberg enabled scalable, reproducible biobanking workflows essential for large cohort studies in cancer and cardiovascular disease—directly supporting the discovery of disease mechanisms beyond genetic analysis alone. In a complementary methodological contribution, Lindberg pioneered a liquid chromatography–tandem mass spectrometry (LC-MS/MS) approach for quantifying mucins from sputum using stable isotope-labeled peptides (2012, 7 citations). This work provided a robust, quantitative tool for studying respiratory and mucosal diseases, enhancing the accuracy of protein biomarker measurements. Together, these achievements demonstrate Lindberg’s impact in bridging automation and analytical chemistry to advance translational research, making him a notable figure in the infrastructure of modern biomedical science.

Research Focus

Key Achievements

2
H-Index
2
Papers
23
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Semi‐automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies
16 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Lund University, AstraZeneca (Sweden)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago